- Novartis not joining the 'frenzy' of weight loss drugs, CEO sayson September 18, 2024 at 8:33 am
Swiss pharmaceutical giant Novartis said Wednesday that it does not plan to enter into the "frenzy" of weight loss drugs.
- 23andMe CEO Anne Wojcicki 'surprised and disappointed' by board resignations: Read the memoon September 18, 2024 at 3:29 am
In a memo to employees on Tuesday, 23andMe CEO Anne Wojcicki said the company will search for new directors.
- Healthy Returns: How competitive can Roche be in the weight loss drug market?on September 17, 2024 at 7:00 pm
Roche presented early-stage data on its obesity injection and pill at EASD. Meanwhile, Oura enters into metabolic health market with acquisition of Veri.
- FDA clears Apple's sleep apnea detection feature for use. Here's how it workson September 16, 2024 at 7:12 pm
The U.S. Food and Drug Administration on Monday cleared Apple's new sleep apnea detection feature for use.
- Drugmakers bet billions that targeted radiation could become the next cancer breakthroughon September 16, 2024 at 3:30 pm
Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind Novartis' Pluvicto.
- Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial resultson September 16, 2024 at 12:59 pm
The results could pave the way for Pfizer's drug ponsegromab to become the first-ever approved treatment specifically for cancer cachexia.
- Moderna shares plunge on plans to cut $1.1 billion in costs, launch 10 new products by 2027on September 12, 2024 at 3:50 pm
Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.
Click Advertiser ♥
Your text ad here $25 per month